Articles published by Clearmind Medicine Inc.
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
Clearmind Medicine Announces 1-for-30 Reverse Share Split
November 21, 2023
Via GlobeNewswire
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
Clearmind Medicine Announces Shareholders Meeting Results
November 15, 2023
Via GlobeNewswire
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
![](https://ml.globenewswire.com/media/0777b20d-1f01-4def-a3c1-977bf158492c/small/cmnd-logo-1-png.png)
Clearmind Medicine to Present at the 8th Annual Dawson James Conference on October 12th
October 05, 2023
Via GlobeNewswire
Tickers
CMND
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
Clearmind Medicine Closes US$2.25 Million Public Offering
September 18, 2023
Via GlobeNewswire
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
Clearmind Medicine Announces Pricing of US$2.25 Million Public Offering
September 14, 2023
Via GlobeNewswire
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
Clearmind Medicine Closes US$3.5 Million Public Offering
April 06, 2023
Via GlobeNewswire
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.